Abstract
Purpose
Chemotherapy-induced peripheral neuropathy (CIPN) is a common and debilitating side effect of chemotherapy. Acupuncture is a promising non-pharmacological intervention for CIPN. However, the physiological effects of acupuncture treatment remain poorly understood. We examined the effects of acupuncture on CIPN using semi-objective quantitative sensory testing (QST).
Methods
We conducted a randomized controlled trial of real acupuncture (RA) and sham acupuncture (SA) compared to usual care (UC) in cancer survivors with moderate-to-severe CIPN. Treatment response was assessed with QST measures of tactile and vibration detection thresholds in hands and feet, thermal detection, and pain thresholds at weeks 0, 8, and 12. Constrained linear mixed model (cLMM) regression was used for statistical analysis.
Results
63 patients completed QST testing. At week 8, vibrational detection thresholds in feet were significantly lower in RA and SA (p = 0.019 and p = 0.046) than in UC, with no difference between RA and SA (p = 0.637). Both RA and SA also showed significantly higher cool thermal detection than UC (p = 0.008 and p = 0.013, respectively), with no difference between RA and SA (p = 0.790). No differences in tactile detection, vibrational detection in hands, warm thermal detection, and thermal pain thresholds were detected among the three arms at weeks 8 and 12.
Conclusion
QST demonstrated different patterns in RA, SA, and UC. After eight weeks of RA, we observed significant improvements in the vibrational detection threshold in feet and cool thermal detection threshold in hands compared to UC. No significant differences were seen when compared to SA.
Trial Registration: ClinicalTrials.gov (NCT03183037); June 9, 2017.
Similar content being viewed by others
Data availability
The data underlying this article will be shared on reasonable request to the corresponding author.
References
Schneider BP, Hershman DL, Loprinzi C (2015) Symptoms: chemotherapy-induced peripheral neuropathy. Adv Exp Med Biol 862:77–87
Ewertz M, Qvortrup C, Eckhoff L (2015) Chemotherapy-induced peripheral neuropathy in patients treated with taxanes and platinum derivatives. Acta Oncol 54(5):587–591
Seretny M, Currie GL, Sena ES, Ramnarine S, Grant R, MacLeod MR, Colvin LA, Fallon M (2014) Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis. Pain 155(12):2461–2470
Hershman DL, Lacchetti C, Loprinzi CL (2014) Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American society of clinical oncology clinical practice guideline summary. J Oncol Pract 10(6):e421–e424
Bao T, Basal C, Seluzicki C, Li SQ, Seidman AD, Mao JJ (2016) Long-term chemotherapy-induced peripheral neuropathy among breast cancer survivors: prevalence, risk factors, and fall risk. Breast Cancer Res Treat 159(2):327–333
Rolke R, Magerl W, Campbell KA, Schalber C, Caspari S, Birklein F, Treede RD (2006) Quantitative sensory testing: a comprehensive protocol for clinical trials. Eur J Pain 10(1):77–88
Backonja MM, Attal N, Baron R, Bouhassira D, Drangholt M, Dyck PJ, Edwards RR, Freeman R, Gracely R, Haanpaa MH et al (2013) Value of quantitative sensory testing in neurological and pain disorders: NeuPSIG consensus. Pain 154(9):1807–1819
Cata JP, Weng HR, Burton AW, Villareal H, Giralt S, Dougherty PM (2007) Quantitative sensory findings in patients with bortezomib-induced pain. J Pain 8(4):296–306
Hershman DL, Weimer LH, Wang A, Kranwinkel G, Brafman L, Fuentes D, Awad D, Crew KD (2011) Association between patient reported outcomes and quantitative sensory tests for measuring long-term neurotoxicity in breast cancer survivors treated with adjuvant paclitaxel chemotherapy. Breast Cancer Res Treat 125(3):767–774
Hanai A, Ishiguro H, Sozu T, Tsuda M, Yano I, Nakagawa T, Imai S, Hamabe Y, Toi M, Arai H et al (2018) Effects of cryotherapy on objective and subjective symptoms of paclitaxel-induced neuropathy: prospective self-controlled trial. J Natl Cancer Inst 110(2):141–148
Zhi WI, Chen P, Kwon A, Chen C, Harte SE, Piulson L, Li S, Patil S, Mao JJ, Bao T (2019) Chemotherapy-induced peripheral neuropathy (CIPN) in breast cancer survivors: a comparison of patient-reported outcomes and quantitative sensory testing. Breast Cancer Res Treat 178(3):587–595
Zhi WI, Baser RE, Kwon A, Chen C, Li SQ, Piulson L, Seluzicki C, Panageas KS, Harte SE, Mao JJ et al (2021) Characterization of chemotherapy-induced peripheral neuropathy using patient-reported outcomes and quantitative sensory testing. Breast Cancer Res Treat 186(3):761–768
Lin D, De La Pena I, Lin L, Zhou SF, Borlongan CV, Cao C (2014) The neuroprotective role of acupuncture and activation of the BDNF signaling pathway. Int J Mol Sci 15(2):3234–3252
Zhao ZQ (2008) Neural mechanism underlying acupuncture analgesia. Prog Neurobiol 85(4):355–375
Vickers AJ, Vertosick EA, Lewith G, MacPherson H, Foster NE, Sherman KJ, Irnich D, Witt CM, Linde K, Acupuncture Trialists C (2018) Acupuncture for chronic pain: update of an individual patient data meta-analysis. J Pain 19(5):455–474
Schroeder S, Meyer-Hamme G, Epplee S (2012) Acupuncture for chemotherapy-induced peripheral neuropathy (CIPN): a pilot study using neurography. Acupunct Med 30(1):4–7
Wong R, Sagar S (2006) Acupuncture treatment for chemotherapy-induced peripheral neuropathy–a case series. Acupunct Med 24(2):87–91
Rostock M, Jaroslawski K, Guethlin C, Ludtke R, Schroder S, Bartsch HH (2013) Chemotherapy-induced peripheral neuropathy in cancer patients: a four-arm randomized trial on the effectiveness of electroacupuncture. Evid Based Complement Alternat Med 2013:349653
D’Alessandro EG, Nebuloni Nagy DR, de Brito CMM, Almeida EPM, Battistella LR, Cecatto RB (2019) Acupuncture for chemotherapy-induced peripheral neuropathy: a randomised controlled pilot study. BMJ Support Palliat Care. https://doi.org/10.1136/bmjspcare-2018-001542
Lu W, Giobbie-Hurder A, Freedman RA, Shin IH, Lin NU, Partridge AH, Rosenthal DS, Ligibel JA (2020) Acupuncture for chemotherapy-induced peripheral neuropathy in breast cancer survivors: a randomized controlled pilot trial. Oncologist 25(4):310–318
Bao T, Patil S, Chen C, Zhi IW, Li QS, Piulson L, Mao JJ (2020) Effect of acupuncture vs sham procedure on chemotherapy-induced peripheral neuropathy symptoms: a randomized clinical trial. JAMA Netw Open 3(3):e200681
Bao T, Baser R, Chen C, Weitzman M, Zhang YL, Seluzicki C, Li QS, Piulson L, Zhi WI (2021) Health-related quality of life in cancer survivors with chemotherapy-induced peripheral neuropathy: a randomized clinical trial. Oncologist. 26(11):e2070–e2078
Drobek W, De Laat A, Schoenaers J (2001) Tactile threshold and pressure pain threshold during treatment of orofacial pain: an explorative study. Clin Oral Invest 5(3):185–193
Kenward MG, White IR, Carpenter JR (2010) Should baseline be a covariate or dependent variable in analyses of change from baseline in clinical trials? by G. F. Liu, K. Lu, R. Mogg, M. Mallick and D. V. Mehrotra statistics in medicine 2009; 28:2509-2530. Stat Med 29(13):1455–145
Team RC (2021) R: a language and environment for stastical computing. R Foundation for Statistical Computing, Vienna
Bates D, Machler M, Bolker BM, Walker SC (2015) Fitting linear mixed-effects models using lme4. J Stat Softw 67(1):1–48
Lenth RV. 2021 emmeans: Estimated Marginal Means, aka Least-Squares Means. In R package version 1.6.3
Giesecke T, Gracely RH, Grant MA, Nachemson A, Petzke F, Williams DA, Clauw DJ (2004) Evidence of augmented central pain processing in idiopathic chronic low back pain. Arthritis Rheum 50(2):613–623
Giesbrecht RJ, Battie MC (2005) A comparison of pressure pain detection thresholds in people with chronic low back pain and volunteers without pain. Phys Ther 85(10):1085–1092
Puta C, Schulz B, Schoeler S, Magerl W, Gabriel B, Gabriel HH, Miltner WH, Weiss T (2012) Enhanced sensitivity to punctate painful stimuli in female patients with chronic low back pain. BMC Neurol 12:98
Edwards RR, Sarlani E, Wesselmann U, Fillingim RB (2005) Quantitative assessment of experimental pain perception: multiple domains of clinical relevance. Pain 114(3):315–319
As-Sanie S, Harris RE, Harte SE, Tu FF, Neshewat G, Clauw DJ (2013) Increased pressure pain sensitivity in women with chronic pelvic pain. Obstet Gynecol 122(5):1047–1055
Pfau DB, Geber C, Birklein F, Treede RD (2012) Quantitative sensory testing of neuropathic pain patients: potential mechanistic and therapeutic implications. Curr Pain Headache Rep 16(3):199–206
Greenspan JD, Slade GD, Bair E, Dubner R, Fillingim RB, Ohrbach R, Knott C, Mulkey F, Rothwell R, Maixner W (2011) Pain sensitivity risk factors for chronic TMD: descriptive data and empirically identified domains from the OPPERA case control study. J Pain 12(11 Suppl):T61-74
Petzke F, Clauw DJ, Ambrose K, Khine A, Gracely RH (2003) Increased pain sensitivity in fibromyalgia: effects of stimulus type and mode of presentation. Pain 105(3):403–413
Kleinbohl D, Holzl R, Moltner A, Rommel C, Weber C, Osswald PM (1999) Psychophysical measures of sensitization to tonic heat discriminate chronic pain patients. Pain 81(1–2):35–43
Reed BD, Sen A, Harlow SD, Haefner HK, Gracely RH (2017) Multimodal vulvar and peripheral sensitivity among women with vulvodynia: a case-control study. J Low Genit Tract Dis 21(1):78–84
Naliboff BD, Munakata J, Fullerton S, Gracely RH, Kodner A, Harraf F, Mayer EA (1997) Evidence for two distinct perceptual alterations in irritable bowel syndrome. Gut 41(4):505–512
Harte SE, Schrepf A, Gallop R, Kruger GH, Lai H, Sutcliffe S, Hartounian S, Halvorson M, Harris RE, Ichesco E et al (2019) Quantitative assessment of non-pelvic pain sensitivity in urological chronic pelvic pain syndrome: a MAPP research network study. Pain. https://doi.org/10.1097/j.pain.0000000000001505
Baron R, Maier C, Attal N, Binder A, Bouhassira D, Cruccu G, Finnerup NB, Haanpaa M, Hansson P, Hullemann P et al (2017) Peripheral neuropathic pain: a mechanism-related organizing principle based on sensory profiles. Pain 158(2):261–272
Lu GW (1983) Characteristics of afferent fiber innervation on acupuncture points zusanli. Am J Physiol 245(4):R606-612
Staff NP, Grisold A, Grisold W, Windebank AJ (2017) Chemotherapy-induced peripheral neuropathy: a current review. Ann Neurol 81(6):772–781
Acknowledgements
The authors would like to extend their gratitude to Patricia Chen for her assistance in conducting this study. The authors would also like to thank all the cancer survivors in the study for their participation.
Funding
This work was supported in part by the National Institutes of Health/National Cancer Institute Cancer Center Support Grant (grant number P30 CA008748), the Translational and Integrative Medicine Research Fund at Memorial Sloan Kettering Cancer Center, and the Frueauff Foundation. The funding sources were not involved in the study design; collection, analysis, and interpretation of the data; writing of the report; or decision to submit the article for publication. Ting Bao is supported by the National Cancer Institute (grant numbers R37CA248563, R01CA240417, R01CA251470). W. Iris Zhi is supported by the Gateway for Cancer Research (grant number G-22-1200).
Author information
Authors and Affiliations
Contributions
WIZ and TB contributed to conceptualization/design. TB contributed to provision of study material or patients. DT and YZM contributed to collection and/or assembly of data. WIZ, REB, and TB contributed to data analysis and interpretation. WIZ, REB, DT, YZM, AK, SEH, and TB contributed to manuscript writing. WIZ, REB, DT, YZM, SEH, and TB contributed to final approval of manuscript.
Corresponding author
Ethics declarations
Conflict of interest
We certify that there are no affiliations with or involvement in any organization or entity with any financial interest or other equity interests or non-financial interests that influenced the design, outcome, and submission of this study.
Ethical approval
This study was approved by Memorial Sloan Kettering’s Institutional Review Board and the clinical trial was registered at ClinicalTrials.gov (NCT03183037). All procedures performed in this study involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Zhi, W.I., Baser, R.E., Talukder, D. et al. Mechanistic and thermal characterization of acupuncture for chemotherapy-induced peripheral neuropathy as measured by quantitative sensory testing. Breast Cancer Res Treat 197, 535–545 (2023). https://doi.org/10.1007/s10549-022-06846-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-022-06846-3